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Thomas E. Rohan, MB, BS; Thomas A. Sellers, PhD; Frank E. Speizer, MD; Walter C. Willett, MD; Alicja Wolk, DrMedSci;
and David J. Hunter, MB, BS
Background: Epidemiologic studies have generally reported
positive associations between alcohol consumption and risk for
colorectal cancer. However, findings related to specific alcoholic
beverages or different anatomic sites in the large bowel have been
inconsistent.
Objective: To examine the relationship of total alcohol intake
and intake from specific beverages to the incidence of colorectal
cancer and to evaluate whether other potential risk factors modify
the association.
Design: Pooled analysis of primary data from 8 cohort studies in
5 countries.
Setting: North America and Europe.
Participants: 489 979 women and men with no history of can-
cer other than nonmelanoma skin cancer at baseline.
Measurements: Alcohol intake was assessed in each study at
baseline by using a validated food-frequency questionnaire.
Results: During a maximum of 6 to 16 years of follow-up across
the studies, 4687 cases of colorectal cancer were documented. In
categorical analyses, increased risk for colorectal cancer was lim-
ited to persons with an alcohol intake of 30 g/d or greater (ap-
proximately >2 drinks/d), a consumption level reported by 4% of
women and 13% of men. Compared with nondrinkers, the pooled
multivariate relative risks were 1.16 (95% CI, 0.99 to 1.36) for
persons who consumed 30 to less than 45 g/d and 1.41 (CI, 1.16
to 1.72) for those who consumed 45 g/d or greater. No significant
heterogeneity by study or sex was observed. The association was
evident for cancer of the proximal colon, distal colon, and rectum.
No clear difference in relative risks was found among specific
alcoholic beverages.
Limitations: The study included only one measure of alcohol
consumption at baseline and could not investigate lifetime alcohol
consumption, alcohol consumption at younger ages, or changes in
alcohol consumption during follow-up. It also could not examine
drinking patterns or duration of alcohol use.
Conclusions: A single determination of alcohol intake correlated
with a modest relative elevation in colorectal cancer rate, mainly
at the highest levels of alcohol intake.
Ann Intern Med. 2004;140:603-613. www.annals.org
For author affiliations, see end of text.
Alcohol intake is a potentially modifiable behavior thatmay be related to risk for colorectal cancer (1). Epide-
miologic studies on alcohol consumption and risk for colo-
rectal cancer have reported either null or positive associa-
tions, with risks that are as much as 5-fold higher among
drinkers compared to nondrinkers and with positive asso-
ciations observed more consistently for rectal than colon
cancer (1). Data on risk for cancer at subsites in the colon
have been limited. In general, beer intake has been posi-
tively related to colorectal cancer, whereas findings for
other alcoholic beverages have been inconsistent. Because
analyses have varied across studies, it has been difficult to
account for discrepancies among studies and in dose–
response relationships.
We evaluated the association between alcohol con-
sumption and the incidence of colorectal cancer, including
separate examinations by sex, subsites in the large bowel,
and other potential risk factors, by analyzing the primary
data from 8 large prospective studies from North America
and Europe. Results on alcohol use and occurrence of colo-
rectal cancer have been published for only 4 of these stud-
ies; for each, follow-up in our analysis is longer than that in
the published analysis (2–5).
METHODS
The Pooling Project of Prospective Studies of Diet and
Cancer has been described elsewhere (6). To maximize the
quality and comparability of the studies in the project, we
formulated general inclusion criteria a priori. For the cur-
rent analyses, we identified prospective studies (3–5, 7–12)
that included at least 50 incident cases of colorectal cancer,
assessed long-term dietary intake, had a validation study of
the dietary assessment method or a closely related instru-
ment (13–19) (Wolk A. Personal communication), and
measured alcohol intake.
The person-time of follow-up in the Nurses’ Health
Study was divided into 2 segments to take advantage of the
more detailed dietary assessment in 1986. In the underly-
ing theory of survival-data analysis, blocks of person-time
in different periods are asymptotically uncorrelated, regard-
less of the extent to which they are derived from the same
people (20).
Exclusion Criteria
We first applied the exclusion criteria for each study,
and then excluded participants with implausible energy in-
takes (3 SDs from the study-specific loge-transformed
mean energy intake), no information on alcohol intake, or
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a history of cancer other than nonmelanoma skin cancer at
baseline.
Case Definition
Incident colorectal cancers were ascertained in each
study by self-report with subsequent medical record review
(3, 11) or linkage with a cancer registry (8, 21–24) or both
(25). Some studies used additional linkage with a death
registry (3, 8, 11, 23–25).
Dietary Assessment
Each study provided data on food, nutrient, and alco-
hol intake as estimated by a baseline food-frequency ques-
tionnaire. All studies but 1 measured usual consumption of
individual alcoholic beverages (beer, wine, and liquor); in
the New York State Cohort, 1 question on the consump-
tion of alcoholic beverages was asked. The format of the
questionnaires varied. Some (5, 9) allowed participants to
indicate both the frequency of drinking and the usual
number of drinks consumed on each occasion; others (3, 4,
11, 12) had participants choose among categories of total
usual consumption. Most of the questionnaires assumed a
standard drink size, but the Canadian National Breast
Screening Study allowed participants to indicate a different
drink size from the standard indicated and the Alpha-
Tocopherol Beta-Carotene Cancer Prevention Study al-
lowed participants to choose from 1 of 3 portion sizes.
Each study calculated alcohol intake in grams per day by
using the reported frequency of consumption, quantity
consumed, and alcohol content of that beverage. For con-
text, in the United States, we assumed that there is 12.8 g
of alcohol in 12 oz (335 mL) of beer, 10.9 g in 4 oz (118
mL) of wine, and 14.0 g in 1.5 oz (44 mL) of 80-proof
liquor (26). Spearman correlation coefficients comparing
alcohol intake from the dietary questionnaires used in the
studies with diet records or 24-hour dietary recalls gener-
ally exceeded 0.7 (Wolk A. Personal communication) (16,
17, 19).
Among dietary covariates, no data on nutrients were
Table 1. Characteristics of the Cohort Studies Included in the Pooled Analysis
Study Population Follow-up Period Method of Follow-up
Alpha-Tocopherol Beta-Carotene
Cancer Prevention Study
Randomized clinical trial among men who
smoked 5 cigarettes/d and lived in
southwestern Finland
1985–1995 Cancer and death registry
Canadian National Breast
Screening Study
Multicenter randomized, controlled trial of
mammography screening for female breast
cancer in Canada
1980–1993 Cancer and death registry
Health Professionals Follow-up
Study
Male dentists, optometrists, osteopathic
physicians, podiatrists, pharmacists, or
veterinarians in the United States
1986–1996 Follow-up questionnaire
and death registry
Iowa Women’s Health Study Postmenopausal women selected randomly
from the 1985 Department of
Transportation’s driver’s license list in Iowa
1986–1998 Cancer and death registry
Netherlands Cohort Study Men and women from 204 municipal
population registries throughout the
Netherlands
1986–1993 Cancer registry
New York State Cohort Male and female residents of New York State
who had had the same address and
telephone number for the previous 18 years
1980–1987 Cancer registry
Nurses’ Health Study a Female registered nurses in the United States 1980–1986 Follow-up questionnaire
and death registry
Nurses’ Health Study b Female registered nurses in the United States 1986–1996 Follow-up questionnaire
and death registry
Sweden Mammography Cohort Mammography screening among women in 2
counties in central Sweden
1987–1998 Cancer registry
Total
* Cancer outcomes in the New York State Cohort were identified through linkage with a cancer registry; thus, it is difficult to determine the follow-up rate in the cohort.
When a subset of the cohort was followed intensively, loss to follow-up was not related to exposure.
† This value represents a subset of the women included in the Nurses’ Health Study a and is not included in the total.
Context
Studies suggest that alcohol consumption increases colo-
rectal cancer risk, but the magnitude of the association
and its relationship to type of alcoholic beverage and can-
cer site are ill defined.
Contribution
This pooled analysis of 8 observational studies showed a
small absolute increase in colorectal cancer risk with alco-
hol consumption of 30 g/d or greater (equivalent to 150
mL of wine), with the greatest risk among people who
consumed 45 g/d or greater. Risk did not differ by bever-
age type or for cancer site.
Cautions
This analysis relied on a single baseline self-report of alco-
hol consumption.
Implications
Clinicians should factor the small increased risk for colorec-
tal cancer into discussions with patients about alcohol’s
risks and benefits.
–The Editors
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missing. Intake of red meat and milk was assessed, and
fewer than 1% of values were missing in most studies.
Nondietary Covariates
Each study collected information on nondietary co-
variates by using self-administered questionnaires at base-
line. Most studies assessed age; smoking habits; physical
activity; education; height; body weight; multivitamin use;
and, among women, use of oral contraceptives and post-
menopausal hormone replacement therapy. The propor-
tion of missing values generally was less than 5% in each
study that measured the covariate. We categorized the co-
variate information in a consistent manner across studies.
Statistical Analysis
Alcohol intake was divided into categories by using
identical cut-points across the studies. Because the number
of cases in higher categories was limited, the cut-point for
the highest category was lower in some analyses. To calcu-
late the P value for the test for trend, participants were
assigned the median value of their category of alcohol, and
this value was used as a continuous variable in the study-
specific regression models.
Each study was analyzed by using the Cox propor-
tional hazards model. Incidence rate ratios were estimated
by using SAS PROC PHREG (27) for all studies except
the Canadian National Breast Screening Study and the
Netherlands Cohort Study, which were analyzed as case–
cohort studies (28) by using Epicure software (29). For all
studies, we stratified participants by age at baseline and the
year that the baseline questionnaire was returned. Person-
years of follow-up were calculated from the date of return
of the baseline questionnaire until the date of diagnosis of
colorectal cancer, death, or end of follow-up, whichever came
first. We conducted sex-specific analyses; studies that included
both sexes were analyzed as two separate cohorts. An indicator
variable for missing responses was created for each covariate
in a study, if needed. Two-sided 95% CIs were calculated.
To obtain a single pooled estimate, we used a random-
effects model to combine loge relative risks from the indi-
vidual studies (30). The study-specific relative risks were
weighted by the inverse of the sum of their variance and
the estimated between-studies variance component. In
some studies, no cases were included in the categories of
higher alcohol intake and the number of noncases in the
corresponding category was very small relative to the sam-
ple size. We did not include these studies in the pooled
estimates for those categories. We tested for heterogeneity
among studies by using the Q statistic (30, 31).
We tested whether the associations for alcohol from
beer, wine, and liquor differed by using a contrast test of
the pooled estimates for each beverage and their covariance
matrix from the random-effects model. The test statistic
follows approximately a chi-square distribution with 2 de-
grees of freedom (32).
We tested for variation in relative risks by other po-
tential risk factors by using a meta-regression model (33).
We also evaluated associations for subsites of the large
bowel and used a Wald test to test the null hypothesis of
no difference among the loge rate ratios (32, 34).
Table 1—Continued
Estimated Rate of
Follow-up
Age Range at
Baseline
Size of the Cohort
at Baseline
Questions on
Alcohol Intake
Cases of Colorectal
Cancer
% y 4OOOOOOOOOOOOOOOOOOOnOOOOOOOOOOOOOOOOOOO3
100 50–69 26 987 6 184
100 40–59 56 837 3 284
94 40–75 47 673 4 408
98 55–69 34 603 4 796
95 55–69 120 852 6 1126
–* 15–107 52 913 1 789*
94 34–59 88 651 3 220
94 40–65 68 540† 4 420
98 40–76 61 463 5 460
489 979 4687
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Role of the Funding Source
The research was funded by the National Institutes of
Health and by the National Colorectal Cancer Research
Alliance. The funding source had no role in the design,
conduct, or reporting of the data.
RESULTS
Of the 8 studies in this analysis, 2 were conducted
among health professionals (3, 11), 3 were population-
based (4, 5, 9), 2 were conducted in screening programs (8,
12), and 1 was originally a randomized clinical trial (7)
(Table 1). During a maximum of 6 to 16 years of fol-
low-up across the studies, 4687 cases of colorectal cancer
were documented, of which 3291 (70%) were colon can-
cer, 1628 were proximal colon cancer, and 1410 were dis-
tal colon cancer. Across studies, 45% to 78% of women
and 76% to 89% of men consumed alcohol (Table 2).
Among drinkers, the mean alcohol intake was 3.5 to 10.9
g/d in women and 12.1 to 20.3 g/d in men.
We calculated study-specific relative risks for alcohol
intake and colorectal cancer, which were subsequently
pooled. Total alcohol intake was positively associated with
risk for colorectal cancer (Table 3). The elevated risk was
limited to alcohol intake of 30 g/d or more. The pooled
age-adjusted relative risks were 1.21 (95% CI, 1.04 to
1.42) for alcohol intake of 30 to less than 45 g/d and 1.51
(CI, 1.25 to 1.83) for intake of 45 g/d or greater, com-
pared with nondrinkers. The test for heterogeneity among
studies was not significant for alcohol consumption of 45
g/d or greater (P  0.2), indicating that the differences in
relative risks among the cohorts were compatible with ran-
dom variation. The relative risks were slightly attenuated
after adjustment for other potential risk factors for colorec-
tal cancer. A significant trend also was observed when non-
drinkers were excluded from the analysis (P  0.001).
Because metabolism of alcohol is slower in women
than men (35), the association with colorectal cancer may
differ by sex. However, results were similar for women and
men (P for heterogeneity due to sex for consumption of 45
g/d or greater 0.2). The positive associations for alcohol
intake of 30 g/d or greater and colorectal cancer were gen-
erally consistent across studies (Figure 1). Additional ad-
justment for intake of total vitamin E, methionine, fiber,
and total fat did not materially change the results (data not
shown). Adjustment for age at menarche, menopausal sta-
tus, parity, and age at first birth did not alter the results
among women (data not shown). The findings were similar
in analyses that excluded cases diagnosed within the first 4
years of follow-up (data not shown). The pooled relative
risks also did not appreciably differ from those obtained
when studies were combined into 1 data set (data not
shown).
We calculated the population attributable risk, which
is the proportion of cases that would be avoided if the risk
factor distribution of a high-risk group switched to that of
a low-risk group (36, 37), by using the age-adjusted relative
risk and the prevalence of alcohol intake of 30 g/d or
greater (4% for women and 13% for men) from the anal-
ysis that combined studies of the same sex into a single data
set. The population attributable risk was 0.9% for women
and 5.0% for men.
The association between alcohol consumption and
colorectal cancer risk was slightly J-shaped. We hypothe-
sized that this pattern may have occurred because the ref-
erence group of nondrinkers included both never-drinkers
and past drinkers, and past drinkers may have an elevated
Table 2. Distribution of Alcohol Intake
Study Participants Who Drink Alcohol* Mean Alcohol Intake among Drinkers ± SD Person-Years
of Alcohol
Intake >45
g/d†
Any
Alcohol
Beer Wine Liquor Total Alcohol Alcohol from
Beer
Alcohol from
Wine
Alcohol from
Liquor
4OOOOOOO%OOOOOOO3 4OOOOOOOOOOOOOg/dOOOOOOOOOOOOO3
Alpha-Tocopherol Beta-Carotene
Cancer Prevention Study
89 71 21 81 20.3  21.8 9.4  13.9 4.3  7.6 12.2  14.2 9.7
Canadian National Breast
Screening Study
77 26 67 52 10.9  14.5 3.5  6.2 6.1  8.8 6.6  11.5 2.2
Health Professionals Follow-up
Study
76 55 59 52 14.8  16.1 6.5  10.0 4.8  6.8 9.2  12.8 4.2
Iowa Women’s Health Study 45 18 30 26 8.7  12.3 6.5  11.3 3.0  4.5 7.1  10.9 0.9
Netherlands Cohort Study
Women 68 9 65 13 8.5  10.6 3.0  5.0 6.8  8.6 8.5  10.4 0.9
Men 85 58 51 58 17.3  16.7 6.3  10.0 7.4  9.7 12.5  12.9 5.2
New York State Cohort
Women 78 – – – 6.0  9.4 – – – 0.9
Men 89 – – – 12.1  17.1 – – – 5.0
Nurses’ Health Study
a 68 22 55 44 9.4  11.6 5.6  9.4 4.5  6.4 6.3  9.1 1.2
b 64 21 53 37 9.6  12.1 4.8  8.8 4.9  7.0 7.1  10.5 1.3
Sweden Mammography Cohort 67 52 48 25 3.5  3.5 1.5  1.9 2.8  2.5 1.2  1.1 0.02
Total 2.2
* The percentage of participants who drank beer, wine, and liquor does not add up to the percentage of total drinkers because of overlap of intake.
† Person-years for the Canadian National Breast Screening Study and Netherlands Cohort Study were obtained from the subcohort and cases from outside of the subcohort.
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risk for colorectal cancer (3, 38). Information on alcohol
consumption during the past 5 to 10 years was available
from only 4 studies (proportion of past drinkers among
nondrinkers, 5% to 56%). For these studies, compared
with nondrinkers (which included never-drinkers and past
drinkers), the pooled multivariate relative risks for increas-
ing categories of alcohol intake (0 g/d, 0 to 5 g/d, 5 to
15 g/d, 15 to 30 g/d, 30 to 45 g/d, and 45 g/d)
Figure. Study-specific and pooled multivariate relative risks for colorectal cancer for alcohol intake of 30 g/d or greater versus 0 g/d.
The black squares and horizontal lines show the study-specific relative risks and 95% CIs. The area of the black squares indicates the study-specific weight
in the pooled analysis. The diamond represents the pooled relative risk and 95% CI. ATBC Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study; CNBSS Canadian National Breast Screening Study; HPFS Health Professionals Follow-up Study; IWHS Iowa Women’s Health Study;
NLCS Netherlands Cohort Study; NYS New York State Cohort; NHS Nurses’ Health Study. The Sweden Mammography Cohort was not
included because no patients with colorectal cancer and only 36 persons without colorectal cancer consumed 30 or more g of alcohol daily. P for test for
between-study heterogeneity 0.2.
Table 3. Pooled Relative Risks for Colorectal Cancer for Categories of Total Alcohol Intake
Variable Alcohol Intake P Value*
0 g/d >0 to <5 g/d 5 to <15 g/d 15 to <30 g/d 30 to <45 g/d >45 g/d
Median intake, g/d† 0.0 1.9 9.4 20.8 35.6 57.1
Cases of colorectal cancer, n 1466 1475 849 485 244 168
Person-years‡ 1 032 388 1 189 623 645 970 255 990 126 763 71 439
Age-adjusted relative risk
(95% CI) 1.00 0.94 (0.85–1.03) 0.98 (0.89–1.08) 1.04 (0.89–1.22) 1.21 (1.04–1.42) 1.51 (1.25–1.83) 0.001§
Multivariate relative risk
(95% CI)
Overall 1.00 0.94 (0.86–1.03) 0.97 (0.88–1.06) 1.01 (0.86–1.18) 1.16 (0.99–1.36) 1.41 (1.16–1.72) 0.001§
Women 1.00 0.96 (0.88–1.05) 1.00 (0.89–1.13) 0.99 (0.78–1.25) 1.19 (0.94–1.50) 1.41 (0.98–2.02) 0.05§
Men 1.00 0.87 (0.63–1.19) 0.90 (0.77–1.07) 1.04 (0.82–1.31) 1.11 (0.86–1.45) 1.41 (1.11–1.79) 0.001§
* Test for trend.
† Median intake for each category was calculated as [(the median intake of each category in each study  the number of participants in the category in each study)]/total
participants in the category across studies.
‡ Person-years for the Canadian National Breast Screening Study and Netherlands Cohort Study were obtained from the subcohort and the cases from outside of the subcohort.
§ P  0.2 for between-study heterogeneity for the highest intake category and for between-study heterogeneity due to sex for the highest intake category.
 Multivariate relative risk was adjusted for smoking (never-smoker, past smoker  20 years’ duration, past smoker 20 to 39 years’ duration, past smoker 40 years’ duration,
current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’
duration, or current smoker 25 cigarettes/d and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2), education (less than high school
graduate, high school graduate, or more than high school graduate), height (1.60 m, 1.60 to 1.65 m, 1.65 m to 1.70 m, 1.70 m to 1.75 m, or 1.75 m for women
and 1.70 m, 1.70 to 1.75 m, 1.75 to 1.80 m, 1.80 to 1.85 m, or 1.85 m for men), degree of physical activity (low, medium, or high), family history of colorectal
cancer (no or yes), use of nonsteroidal anti-inflammatory drugs (no or yes), use of multivitamins (no, yes 6 times/wk, yes 6 times/wk, or yes but missing dose for the
Health Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study; no or yes for the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study,
Canadian National Breast Screening Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), red meat intake (quartiles), total milk
intake (quartiles) and folate intake from food only (quintiles). For women, the relative risks were also adjusted for history of use of oral contraceptives (no or yes) and
postmenopausal hormone therapy (ever or never).
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were 1.00, 0.93, 0.90, 0.98, 1.27, and 1.56 (CI, 1.20 to
2.04), respectively. When past drinkers were excluded from
the reference group, the corresponding relative risks
changed to 1.00, 0.95, 0.92, 0.99, 1.32, and 1.65 (CI,
1.24 to 2.21).
In analyses of each alcoholic beverage, alcohol from
beer or wine was significantly associated with an elevated
risk for colorectal cancer and alcohol from liquor had a
nonsignificant positive association with risk for colorectal
cancer (Table 4). The difference among the 3 types of
beverage was not statistically significant.
The positive association between alcohol consumption
and risk for colorectal cancer was similar across all areas of
the large bowel (P for heterogeneity by subsite for con-
sumption of 45 g/d or greater 0.2) (Table 5). We also
examined associations between alcohol intake from indi-
vidual beverages and colon cancer and rectal cancer (Table
6). Although all beverages tended to be more strongly re-
lated to rectal than to colon cancer, the differences in rel-
ative risks between colon cancer and rectal cancer did not
differ significantly.
We examined interactions between alcohol intake and
other potential factors related to risk for colorectal cancer
(Table 7). The positive association between alcohol intake
and colorectal cancer was pronounced among persons with
a lower body mass index. The elevated risk among leaner
persons was somewhat stronger in men than in women (P
for heterogeneity by sex 0.11). The relative risk for colo-
rectal cancer with an alcohol intake of 30 g/d or greater
was 1.60 (CI, 1.07 to 2.41) for women and 3.51 (CI, 1.45
to 8.50) for men with a body mass index less than 22
kg/m2. These results did not change materially after exclu-
sion of cases that were diagnosed during the first 3 years of
follow-up (data not shown).
The association between alcohol use and colorectal
cancer did not vary by other factors (Table 7). However,
there was a weak suggestion that the positive association
between alcohol consumption and risk for colorectal cancer
was restricted to persons who did not take multivitamins.
In addition, when examined by levels of methionine in-
take, the positive association was observed only among per-
sons in the 2 lowest tertiles of intake. The association be-
tween alcohol consumption and risk for colorectal cancer
did not differ by use of hormone replacement therapy
(never, past, or current) among postmenopausal women
(data not shown).
DISCUSSION
In this pooled analysis of cohort studies, alcohol con-
sumption was positively associated with risk for colorectal
cancer. The relationship was consistent in women and men
and across studies. The positive association existed for
proximal colon cancer, distal colon cancer, and rectal can-
Table 4. Pooled Relative Risk for Colorectal Cancer for Categories of Alcohol Intakes from Specific Beverages*
Source of Alcohol Alcohol Intake P Value†
0 g/d >0 to <30 g/d >30 g/d
Beer
Cases of colorectal cancer, n 2612 1219 67
Person-years 1 890 206 1 003 371 47 083
Age-adjusted relative risk (95% CI) 1.00 1.02 (0.93–1.12) 1.47 (1.13–1.92) 0.06‡
Multivariate relative risk (95% CI)§ 1.00 1.01 (0.89–1.13) 1.37 (1.00–1.87) 0.2‡
Wine
Cases of colorectal cancer, n 2078 1768 52
Person-years 1 515 247 1 416 395 9019
Age-adjusted relative risk (95% CI) 1.00 0.98 (0.90–1.06) 1.74 (1.25–2.42) 0.002‡
Multivariate relative risk (95% CI)§ 1.00 0.97 (0.89–1.05) 1.82 (1.28–2.59) 0.001‡
Liquor
Cases of colorectal cancer, n 2392 1347 159
Person-years 1 767 551 1 088 350 84 761
Age-adjusted relative risk (95% CI) 1.00 1.00 (0.92–1.09) 1.30 (1.05–1.60) 0.04‡
Multivariate relative risk (95% CI)§ 1.00 0.98 (0.88–1.09) 1.21 (0.99–1.47) 0.1‡
* The New York State Cohort was not included in the analyses on alcohol from beer, wine, and liquor. Person-years for the Canadian National Breast Screening Study and
Netherlands Cohort Study were obtained from the subcohort and the cases from outside of the subcohort.
† Test for trend.
‡ P  0.2 for between-study heterogeneity for the highest intake category and for between-study heterogeneity due to sex for the highest intake category.
§ Multivariate relative risk was adjusted for smoking (never-smoker, past smoker 20 years’ duration, past smoker 20 to 39 years’ duration, past smoker 40 years’ duration,
current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’
duration, or current smoker 25 cigarettes/d and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2), education (less than high school
graduate, high school graduate, or more than high school graduate), height (1.60 m, 1.60 to 1.65 m, 1.65 m to 1.70 m, 1.70 m to 1.75 m, or 1.75 m for women
and 1.70 m, 1.70 to 1.75 m, 1.75 to 1.80 m, 1.80 to 1.85 m, or 1.85 m for men), degree of physical activity (low, medium, or high), family history of colorectal
cancer (no or yes), use of nonsteroidal anti-inflammatory drugs (no or yes), use of multivitamins (no, yes 6 times/wk, yes 6 times/wk, or yes but missing dose for the
Health Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study; no or yes for the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study,
Canadian National Breast Screening Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), red meat intake (quartiles), total milk
intake (quartiles) and folate intake from food only (quintiles) and alcohol intake from the other beverages. For women, the relative risks were also adjusted for history of use
of oral contraceptives (no or yes) and postmenopausal hormone therapy (ever or never).
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cer. The risk did not differ significantly by type of alco-
holic beverage.
Several mechanisms have been suggested for the effect
of alcohol on risk for colorectal cancer. First, acetaldehyde,
an oxidation product of alcohol, may be responsible for
colorectal carcinogenesis (39, 40). A recent study reported
that high levels of acetaldehyde in rat colon degrade folate,
a nutrient that is hypothesized to reduce the risk for colo-
rectal cancer (41). Second, alcohol is an antagonist of
methyl-group metabolism and may contribute to abnormal
DNA methylation, an early step in colonic carcinogenesis
(42, 43). Finally, greater alcohol intake may increase the
risk for colorectal cancer indirectly through immune sup-
pression, delay of DNA repair, activation of liver procar-
cinogens by induction of cytochrome P-450 enzymes, or
changes in bile acid composition (44).
Epidemiologic studies on alcohol consumption and
colorectal cancer have reported positive or null associations
(1). A meta-analysis of 5 cohorts (none of which was in-
cluded in our analysis) and 22 case–control studies re-
Table 5. Pooled Multivariate Relative Risk by Subsite of Colorectal Cancer according to Alcohol Intake*
Subsite† Relative Risk (95% CI) by Alcohol Intake P Value‡
0 g/d >0 to <5 g/d 5 to <15 g/d 15 to <30 g/d 30 to <45 g/d >45 g/d Test for
Trend
Test for Trend,
Excluding Intake
of 0 g/d
Colon (n  3291) 1.00 0.92 (0.84–1.01) 0.94 (0.84–1.05) 1.01 (0.82–1.24) 1.08 (0.89–1.31) 1.45 (1.14–1.83) 0.001 0.001
Proximal colon (n  1628) 1.00 0.90 (0.77–1.04) 0.88 (0.75–1.04) 0.99 (0.80–1.21) 0.98 (0.74–1.29) 1.35 (0.97–1.89) 0.03 0.01
Distal colon (n  1410) 1.00 0.94 (0.81–1.09) 1.01 (0.85–1.20) 1.02 (0.74–1.40) 1.25 (0.92–1.68) 1.66 (1.17–2.36) 0.04 0.01
Rectum (n  1370) 1.00 1.01 (0.83–1.22) 0.99 (0.82–1.19) 1.05 (0.83–1.32) 1.42 (1.07–1.88) 1.49 (1.04–2.12) 0.006 0.02
* Relative risks were adjusted for smoking (never-smoker, past smoker  20 years’ duration, past smoker 20 to 39 years’ duration, past smoker 40 years’ duration, current
smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, or
current smoker 25 cigarettes/d and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2), education (less than high school graduate, high
school graduate, or more than high school graduate), height (1.60 m, 1.60 to 1.65 m, 1.65 m to 1.70 m, 1.70 m to 1.75 m, or 1.75 m for women and 1.70
m, 1.70 to 1.75 m, 1.75 to 1.80 m, 1.80 to 1.85 m, or 1.85 m for men), degree of physical activity (low, medium, or high), family history of colorectal cancer (no
or yes), use of nonsteroidal anti-inflammatory drugs (no or yes), use of multivitamins (no, yes 6 times/wk, yes 6 times/wk, or yes but missing dose for the Health
Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study; no or yes for the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study,
Canadian National Breast Screening Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), red meat intake (quartiles), total milk
intake (quartiles) and folate intake from food only (quintiles). For women, the relative risks were also adjusted for history of use of oral contraceptives (no or yes) and
postmenopausal hormone therapy (ever or never).
† Colon cancers were considered those from the cecum through the sigmoid colon. Tumors from the cecum to the splenic flexure were considered to be proximal colon
cancer. The remaining tumors in the colon were defined as distal colon cancers. Rectal cancers included tumors in the rectum and the rectosigmoid junction.
‡ P  0.2 for between-study heterogeneity for the highest intake category, for between-study heterogeneity due to sex for the highest intake category, and for common effects
by subsites (proximal colon, distal colon, and rectum) for the highest intake category.
Table 6. Pooled Multivariate Relative Risks by Subsite of Colorectal Cancer according to Intake of Alcohol from Specific Beverages*
Type of Alcohol
and Subsite
Relative Risk (95% CI) by Alcohol Intake P Value
0 g/d >0 to <15 g/d >15 g/d Test for Trend Test for Common
Effects by Subsite
for the Highest
Intake Category
Beer
Colon 1.00 0.96 (0.84–1.10) 1.38 (1.05–1.82) 0.08†
Rectum 1.00 1.05 (0.88–1.25) 1.59 (1.12–2.25) 0.005‡ 0.2
Wine
Colon 1.00 0.97 (0.88–1.07) 1.33 (1.00–1.77) 0.03§
Rectum 1.00 0.96 (0.83–1.11) 1.55 (1.11–2.17) 0.009† 0.2
Liquor
Colon 1.00 0.99 (0.88–1.11) 1.06 (0.86–1.30) 0.2†
Rectum 1.00 0.97 (0.81–1.16) 1.10 (0.85–1.41) 0.2† 0.2
* Relative risks were adjusted for smoking (never-smoker, past smoker  20 years’ duration, past smoker 20 to 39 years’ duration, past smoker 40 years’ duration, current
smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, or
current smoker 25 cigarettes/d and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2), education (less than high school graduate, high
school graduate, or more than high school graduate), height (1.60 m, 1.60 to 1.65 m, 1.65 m to 1.70 m, 1.70 m to 1.75 m, or 1.75 m for women and 1.70
m, 1.70 to 1.75 m, 1.75 to 1.80 m, 1.80 to 1.85 m, or 1.85 m for men), degree of physical activity (low, medium, or high), family history of colorectal cancer (no
or yes), use of nonsteroidal anti-inflammatory drugs (no or yes), use of multivitamins (no, yes 6 times/wk, yes 6 times/wk, or yes but missing dose for the Health
Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study; no or yes for the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study,
Canadian National Breast Screening Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), red meat intake (quartiles), total milk
intake (quartiles) and folate intake from food only (quintiles). For women, the relative risks were also adjusted for history of use of oral contraceptives (no or yes) and
postmenopausal hormone therapy (ever or never). They were also simultaneously adjusted for the other beverages.
† P  0.2 for between-study heterogeneity for the highest intake category and for between-study heterogeneity due to sex for the highest intake category.
‡ P  0.2 for between-study heterogeneity for the highest intake category and P  0.17 for between-study heterogeneity due to sex for the highest intake category.
§ P  0.2 for between-study heterogeneity for the highest intake category and P  0.16 for between-study heterogeneity due to sex for the highest intake category.
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ported that the relative risks for colorectal cancer in per-
sons who consumed 2 alcoholic beverages daily were 1.32
(CI, 1.16 to 1.51) and 1.07 (CI, 1.02 to 1.12), respectively
(45). Associations were stronger in case–control studies
that used population controls than those that used hospital
controls (44), possibly because alcohol intake is related to
many conditions requiring hospitalization.
In separate analyses of colon cancer and rectal cancer,
some (46–57) but not all (38, 58–62) studies have re-
ported positive associations between alcohol intake and
rectal cancer. The results have been more mixed for colon
cancer: Some studies (38, 46, 48–50, 54, 56, 57, 63, 64),
but not others (47, 52, 53, 55, 58–62, 65, 66), have found
a positive association. However, we found that alcohol in-
take was positively related to both colon cancer and rectal
cancer, suggesting that statistical power might have been
problematic in previous studies on colon cancer.
Among alcoholic beverages, beer intake has been re-
lated to an increased risk for rectal cancer in most (50–52,
55, 59, 60, 67) but not all (46, 61, 68) studies. The asso-
ciation between beer intake and colon cancer has been
inconsistent (46, 49, 50, 52, 55, 59, 61, 63, 64, 68, 69).
Most studies have reported no association between wine or
liquor intake and colon or rectal cancer (48, 50–52, 60,
61, 63, 67–69); however, a few studies have reported pos-
itive associations for colon cancer (46, 55, 63, 64). We
found that all 3 types of beverage were somewhat positively
associated with colorectal cancer and that the risks among
these beverages did not differ significantly. We also found
a positive association between intake of wine or beer and
risk for both colon and rectal cancers. Thus, our data sug-
gest that the positive association between total alcohol and
colorectal cancer is attributable to ethanol itself rather than
to a specific beverage.
We found that the association between alcohol con-
sumption and risk for colorectal cancer was stronger
among persons with a lower body mass index than in those
with a higher body mass index. This effect may be related
Table 7. Pooled Multivariate Relative Risk by Alcohol Intake and Other Risk Factors for Colorectal Cancer*
Risk Factor Alcohol Intake P Value
0 g/d >0 to <5 g/d 5 to <15 g/d 15 to <30 g/d >30 g/d Test for Trend Test for Interaction
for Highest Intake
Category
Body mass index
22 kg/m2 (n  663) 1.00 1.09 (0.87–1.37) 1.28 (0.98–1.68) 1.11 (0.71–1.72) 1.84 (1.27–2.67) 0.003†
22–25 kg/m2 (n  1503) 1.00 0.85 (0.70–1.03) 0.85 (0.71–1.01) 0.96 (0.76–1.22) 1.23 (0.91–1.65) 0.03‡
25 kg/m2 (n  2414) 1.00 0.96 (0.86–1.07) 0.92 (0.77–1.10) 1.03 (0.84–1.26) 1.08 (0.88–1.33) 0.04‡ 0.03
Multivitamin use§
Nonusers (n  2902) 1.00 0.92 (0.79–1.07) 0.94 (0.83–1.07) 1.01 (0.83–1.23) 1.30 (1.10–1.54) 0.001‡
Users (n  917) 1.00 0.96 (0.80–1.14) 0.96 (0.77–1.20) 0.87 (0.65–1.17) 1.06 (0.77–1.44) 0.2‡ 0.2
Total folate intake
1st tertile (n  1063) 1.00 0.91 (0.75–1.09) 1.01 (0.82–1.24) 0.96 (0.72–1.28) 1.24 (0.96–1.60) 0.07‡
2nd tertile (n  1124) 1.00 0.89 (0.71–1.11) 0.96 (0.79–1.18) 1.01 (0.78–1.30) 1.16 (0.87–1.54) 0.2‡
3rd tertile (n  914) 1.00 1.00 (0.83–1.19) 0.94 (0.68–1.30) 0.82 (0.55–1.22) 1.19 (0.86–1.64) 0.18‡ 0.2
Methionine intake
1st tertile (n  1657) 1.00 0.89 (0.78–1.02) 0.91 (0.77–1.08) 0.91 (0.70–1.17) 1.29 (1.04–1.58) 0.003‡
2nd tertile (n  1562) 1.00 1.01 (0.82–1.25) 1.10 (0.92–1.30) 1.00 (0.78–1.27) 1.39 (0.98–1.95) 0.06¶
3rd tertile (n  1467) 1.00 0.93 (0.75–1.15) 0.91 (0.74–1.11) 1.19 (0.84–1.70) 0.88 (0.56–1.36) 0.2** 0.2
Smoking
Never (n  1723)†† 1.00 0.89 (0.79–1.00) 0.92 (0.78–1.08) 1.09 (0.85–1.39) 1.17 (0.84–1.63) 0.19‡
Past (n  1549)†† 1.00 0.95 (0.81–1.13) 0.91 (0.76–1.09) 1.08 (0.88–1.32) 1.26 (1.00–1.58) 0.04‡
Current (n  904) 1.00 1.14 (0.86–1.49) 1.14 (0.89–1.45) 0.85 (0.64–1.12) 1.42 (1.11–1.83) 0.007‡ 0.2
* Relative risks were adjusted for smoking (never-smoker, past smoker  20 years’ duration, past smoker 20 to 39 years’ duration, past smoker 40 years’ duration, current
smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, current smoker 25 cigarettes/d and 40 years’ duration, or
current smoker 25 cigarettes/d and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2), education (less than high school graduate, high
school graduate, or more than high school graduate), height (1.60 m, 1.60 to 1.65 m, 1.65 m to 1.70 m, 1.70 m to 1.75 m, or 1.75 m for women and 1.70
m, 1.70 to 1.75 m, 1.75 to 1.80 m, 1.80 to 1.85 m, or 1.85 m for men), degree of physical activity (low, medium, or high), family history of colorectal cancer (no
or yes), use of nonsteroidal anti-inflammatory drugs (no or yes), use of multivitamins (no, yes 6 times/wk, yes 6 times/wk, or yes but missing dose for the Health
Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study; no or yes for the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study,
Canadian National Breast Screening Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), red meat intake (quartiles), total milk
intake (quartiles) and folate intake from food only (quintiles). For women, the relative risks were also adjusted for history of use of oral contraceptives (no or yes) and
postmenopausal hormone therapy (ever or never).
† P  0.2 for between-study heterogeneity for the highest intake category and P  0.11 for between-study heterogeneity due to sex for the highest intake category.
‡ P  0.2 for between-study heterogeneity for the highest intake category and for between-study heterogeneity due to sex for the highest intake category.
§ The Canadian National Breast Screening Study and the Sweden Mammography Cohort were not included in this analysis.
 The Canadian National Breast Screening Study, the Netherlands Cohort Study, and the Sweden Mammography Cohort were not included in this analysis.
¶ P  0.14 for between-study heterogeneity for the highest intake category and P  0.17 for between-study heterogeneity due to sex for the highest intake category.
** P  0.15 for between-study heterogeneity for the highest intake category and P  0.2 for between-study heterogeneity due to sex for the highest intake category.
†† The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study was not included in this analysis.
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to the observation that alcohol intake reduces insulin resis-
tance (70), which is strongly related to obesity (71) and
may be related to a higher risk for colorectal cancer (38,
72, 73). Thus, among persons with a higher body mass
index, the adverse effect of alcohol on risk for colorectal
cancer might be offset by the beneficial effects of alcohol
on insulin resistance. Alternatively, because leaner people
have higher blood alcohol concentrations in response to a
fixed dose of alcohol, the same biological mechanism may
be at work.
The effect of alcohol as an antagonist of methyl-group
metabolism may be exacerbated by low levels of folate and
methionine, which also contribute to DNA hypomethyla-
tion (74). We found that the positive association between
alcohol use and risk for colorectal cancer was restricted to
persons who did not take multivitamins, a major contrib-
utor of folate intake. Multivitamins also contain a more
bioavailable form of folate than that in foods (75, 76). The
positive association between alcohol and colorectal cancer
was also not seen in persons who consumed higher
amounts of methionine.
We observed a slightly lower risk for colorectal cancer
with alcohol intake of 0 to less than 5 g/d compared with
nondrinkers, perhaps because the reference group of non-
drinkers includes past drinkers, who may differ from never-
drinkers (for example, past drinkers may have ceased alco-
hol intake because of illness). Previous studies have been
shown that past drinkers are at higher risk for colorectal
cancer than are never-drinkers (3, 38). We had informa-
tion on past alcohol intake from only 4 studies; however,
when we excluded past drinkers from the reference group
of nondrinkers, the association was slightly stronger.
Therefore, including previous drinkers in the reference
group is unlikely to account for the positive association
overall.
Our study had several strengths. First, we specified a
priori that we would include only prospective studies that
used a validated food-frequency questionnaire to estimate
dietary intake. Prospective studies are less vulnerable to
selection and recall biases that may affect case–control
studies of associations between diet and disease. These in-
clusion criteria also minimized sources of variation across
studies due to study design or quality. Results in our anal-
yses were consistent across studies. Second, analysis of the
primary data from these studies has several advantages
compared with conducting a meta-analysis of the pub-
lished literature. We could create identical categories for
alcohol intake and covariates across studies, removing po-
tential sources of heterogeneity that may occur in a meta-
analysis of the published literature. Because the studies
were selected to evaluate relationships of diet with cancer
in general, rather than of alcohol with colorectal cancer, we
also minimized the possibility of including only studies
that had significant findings (publication bias). In fact, we
included 4 studies that have not published data on alcohol
and colorectal cancer.
Our study had several limitations. First, we had only
one measure of alcohol consumption at baseline and could
not investigate lifetime alcohol consumption, alcohol con-
sumption at younger ages, or changes in alcohol consump-
tion during follow-up. Second, we could not examine
drinking patterns or duration of alcohol use. Third, some
of the studies did not measure some risk factors for colo-
rectal neoplasia. However, the pooled multivariate results
were similar to the age-adjusted results, indicating that this
deficiency was not important. Fourth, we did not have
information on screening for colorectal cancer. However,
during the follow-up period of most of the samples, screen-
ing endoscopy and polyp removal were not widespread.
Finally, measurement error on alcohol intake may bias the
results. However, validation data in our studies have gen-
erally supported that alcohol intake was well measured (16,
17, 19) (Wolk A. Personal communication).
Two of the studies also reported strong correlations
between alcohol intake and serum high-density lipoprotein
cholesterol, a biomarker that cannot be affected by biased
reporting (19). Measurement error in other covariates, in-
cluding dietary covariates, may be a concern. However,
because the age-adjusted results were similar to the multi-
variate results, the influence of measurement error in co-
variates should be minimal.
In summary, a single determination of alcohol intake
was associated with a modest relative elevation in risk for
colorectal cancer, mainly for intake of 30 g/d or greater, a
level of intake reported by 4% of women and 13% of men.
Whether this association is causal depends in part on
whether participants in the higher intake groups differ
from the other participants in some unmeasured determi-
nants of risk for colorectal cancer, or whether the potential
confounding factors for which we adjusted were measured
with lesser accuracy in this subset. The associations were
consistent across studies, between men and women, and
across subsites of the large bowel. Although moderate alco-
hol consumption has been associated with a reduced risk
for cardiovascular disease, alcohol intake has been posi-
tively associated with risk for cancers at several sites, in-
cluding the large bowel. Both the risks and benefits of
alcohol intake should be considered in decisions about
drinking.
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